Paola Maria Chiara Perego

Title: Paola Maria Chiara Perego: Innovator in Apoptosis Induction

Introduction

Paola Maria Chiara Perego is a distinguished inventor based in Monza, Italy. She has made significant contributions to the field of cancer therapy through her innovative research and development of novel compounds. With a total of 2 patents, her work focuses on the induction of apoptotic cell death, which is crucial in the treatment of cancer.

Latest Patents

Perego's latest patents include the development of homo- and heterodimeric SMAC mimetic compounds as apoptosis inducers. These inventions relate to conformationally constrained mimetics of Smac that function as inhibitors of Inhibitor of Apoptosis Proteins (IAPs). The compounds are designed for therapeutic use, particularly in inducing apoptotic cell death, which is beneficial in cancer treatment, either alone or in combination with other active ingredients.

Career Highlights

Paola Maria Chiara Perego is currently associated with BioNTech AG, where she continues her groundbreaking work in the field of cancer research. Her innovative approach and dedication to improving therapeutic options for cancer patients have established her as a prominent figure in her field.

Collaborations

Throughout her career, Perego has collaborated with notable colleagues, including Pierfausto Seneci and Laura Belvisi. These partnerships have further enhanced her research and contributed to the advancement of cancer therapies.

Conclusion

Paola Maria Chiara Perego is a remarkable inventor whose work in developing SMAC mimetic compounds has the potential to transform cancer treatment. Her contributions to the field highlight the importance of innovation in medical research and therapy.